Austrian Breast & Colorectal Cancer Study Group

What Austrian Breast & Colorectal Cancer Study Group does

The Austrian Breast & Colorectal Cancer Study Group (ABCSG) is a Vienna-based non-profit academic research organization (Verein) founded in 1984 that designs and conducts clinical trials in breast and colorectal cancer. It operates a national network of Austrian study sites, running both investigator-initiated trials (IITs) and industry-sponsored studies, and serves patients, Austrian oncologists, and global pharmaceutical sponsors. Leadership sits with President Prof. Michael Gnant, with translational research headed by Assoz. Prof. Mag. Dr. Martin Filipits. The work is supported by a senior KOL base and a study nurse/coordinator community that has been built across more than three decades.

ABCSG's core offerings break into three layers. The clinical operations layer covers protocol design, ethics and regulatory submissions, site activation, patient recruitment, data management, and publication of peer-reviewed results. The translational layer is anchored by the abcsg.research tumor bank, which supplies longitudinal breast and colorectal samples for correlative biomarker research. The educational layer is organized under abcsg.academy and includes Forum Study Nurses & Coordinators, Science into Practice, Science and Cases, Experts on Tour, the Interdisziplinärer Mamma Diskurs congress, and the abcsg.future early-career researcher program.

Revenue mechanics are those of an academic non-profit rather than a commercial CRO: funds flow from competitive research grants, per-patient and milestone-based pharmaceutical sponsorship fees for industry trials, and educational grants underwriting the academy and congress programs. Customer segments are effectively three: pharmaceutical sponsors (Roche, Novartis, Pfizer, Lilly, AstraZeneca, Daiichi Sankyo, Gilead, MSD, Stemline, Exact Sciences/Abbott, Agendia) for industry-sponsored trials, Austrian academic and public trial sites, and investigators/coordinators participating in the educational stack. There is no public pricing transparency and no equity capital structure.

Name

Austrian Breast & Colorectal Cancer Study Group

Legal name

Verein zur Prävention und Therapie bösartiger Erkrankungen, Austrian Breast and Colorectal Cancer Study Group (ABCSG)

Website

https://abcsg.org

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

51–100 employees

Short description

The Austrian Breast & Colorectal Cancer Study Group (ABCSG) is a Vienna-based non-profit academic research organization founded in 1984 that runs investigator-initiated and industry-sponsored clinical trials in breast and colorectal cancer across a network of Austrian study sites.

Ownership category

akta.pro rank

Product category

Clinical Research Organization / Oncology Clinical Trials

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical and Diagnostic Laboratories (62151)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA)

akta.pro secondary industries

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC), Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

Keywords

• Clinical trial coordination
• Translational cancer research
• Oncology clinical studies
• Academic research organization
• Continuing medical education

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Research Grants and Institutional Funding: ABCSG operates as an academic research organization funded through grants, pharmaceutical company partnerships, and institutional funding. The organization conducts clinical trials with support from pharmaceutical partners and government/institutional research grants.

Distribution channels1 record

Marketing channels12 records

Core offering

ABCSG is an independent academic non-profit cancer research organization that designs, coordinates, and runs clinical trials in breast and colorectal cancer through a network of Austrian study centers. It also manages a translational research program and tumor bank (abcsg.research) and offers accredited continuing medical education events and investigator training (abcsg.academy) for oncology professionals across Austria.

Product overview

ABCSG (Austrian Breast & Colorectal Cancer Study Group) is an independent academic cancer research organization comprising two entities: the association (Verein) and ABCSG GmbH. The organization's core offering is its clinical trials programs spanning breast and colorectal cancer research, including recruiting studies, treatment phase studies, follow-up studies, and translational research managed through abcsg.research. The portfolio is supported by extensive educational offerings including abcsg.academy for investigator certification, the Forum Study Nurses & Coordinators for clinical research staff training, and multiple event series (Jahrestagung, EXPERTS ON TOUR, Interdisziplinärer Mamma Diskurs, Science into Practice, Science and Cases, Post-SABCS). ABCSG also produces scientific content through its podcast 'Medizin im Kontext', Clinical Opinions publications, Science News, Surgery News video summaries, and annual reports. A password-protected Trial Data Port provides data access, while dedicated studies like ABCSG 50/BRCA-P and recently initiated studies (ABCSG 61/TEODOR, ABCSG 63/ERIKA, ABCSG 65/DEFINITIVE) represent active research projects.

Differentiator

Problem solved

Functional benefit

Brands

• abcsg.research: Translational research division of ABCSG focusing on biomarker research and tumor banking.
• abcsg.academy
• Forum Study Nurses & Coordinators
• abcsg.future
• Science into Practice
• Science and Cases
• Experts on Tour
• Interdisziplinärer Mamma Diskurs

Products and services

• ABCSG Clinical Trials Programs Independent academic clinical trial portfolio in breast and colorectal cancer, including recruiting studies, treatment-phase studies, follow-up studies, and translational research projects conducted across Austrian study centers. Intended for pharmaceutical sponsors, investigators, and cancer patients seeking access to innovative therapies.

Quantifiable outcome

• 30 publications in international peer-reviewed journals in 2025 - the most publication-intensive year in ABCSG history

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

15 partnerships are on record, tiered core.

• Roche AustriacoreStrategic or Co-development PartnerPharmaceutical partner supporting ABCSG clinical trials and educational activities. Roche has been a longstanding supporter of ABCSG research initiatives and annual meetings.
• NovartiscoreStrategic or Co-development PartnerPharmaceutical partner providing support for ABCSG educational programs and clinical research activities. Novartis sponsors Experts on Tour and other ABCSG events.
• PfizercoreStrategic or Co-development PartnerPharmaceutical partner supporting ABCSG clinical trials and continuing medical education activities.
• Lilly (Eli Lilly)coreStrategic or Co-development PartnerPharmaceutical partner sponsoring ABCSG events and supporting oncology research and education in Austria.
• AstraZenecacoreStrategic or Co-development PartnerPharmaceutical partner supporting ABCSG clinical research and educational activities.
• Daiichi SankyocoreStrategic or Co-development PartnerPharmaceutical partner sponsoring ABCSG Experts on Tour educational events.
• Gilead SciencescoreStrategic or Co-development PartnerPharmaceutical partner supporting ABCSG events and activities.
• MSD (Merck Sharp & Dohme)coreStrategic or Co-development PartnerPharmaceutical partner sponsoring ABCSG educational activities.
• Stemline TherapeuticscoreStrategic or Co-development PartnerPharmaceutical partner supporting ABCSG events.
• Exact Sciences (Abbott)coreStrategic or Co-development PartnerDiagnostic and pharmaceutical partner sponsoring ABCSG educational activities.
• AgendiacoreTechnology or IntegrationMolecular diagnostics company providing genomic testing services for breast cancer research, sponsoring ABCSG educational activities.
• SOLTI Cancer Research GroupcoreStrategic or Co-development PartnerSpanish academic oncology research group collaborating with ABCSG on European breast cancer research initiatives. ABCSG participated in the SOLTI Young European Workshop in Barcelona in June 2026.
• Österreichische Gesellschaft für Senologie (Austrian Society of Senology)coreStrategic or Co-development PartnerProfessional society collaborating with ABCSG on the annual Interdisziplinärer Mamma Diskurs educational event.
• Österreichisches Onkologie Forum (Austrian Oncology Forum)coreStrategic or Co-development PartnerIndependent think tank of the Austrian Society for Hematology and Medical Oncology (OeGHO) that developed a joint position paper with ABCSG to strengthen clinical trials in Austria.
• Forum Study Nurses & CoordinatorscoreOthers

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Unicancer: French federation of comprehensive cancer centers running investigator-initiated clinical trials. Comparable to ABCSG as an academic, non-profit clinical research organization but with a broader tumor scope and national French footprint.
• BIG (Breast International Group): International non-profit network coordinating large-scale academic breast cancer trials worldwide. Operates as an umbrella to which many country-level groups contribute; comparable to ABCSG in mission and academic spirit but far larger and globally networked.
• EORTC (European Organisation for Research and Treatment of Cancer): Pan-European academic clinical cancer research organization headquartered in Belgium, running multi-tumor clinical trials across hundreds of European sites. Comparable as a translational/academic oncology trial body, but far larger and broader than ABCSG's Austria-only, two-indication focus.

Direct peers

• NSABP Foundation (National Surgical Adjuvant Breast and Bowel Project): US-based academic research organization running breast and colorectal cancer trials since the 1970s. Nearly identical therapeutic focus (breast and bowel/colorectal), investigator-initiated trials, and translational research portfolio, making it a strong functional analog to ABCSG.
• IBCSG (International Breast Cancer Study Group): International non-profit academic research group running large-scale breast cancer trials across multiple countries. Comparable mission, governance, and funding model (investigator-initiated trials, pharma-supported) as ABCSG, with a global vs. Austria-centric footprint.
• GEICAM (Spanish Breast Cancer Research Group): Spanish non-profit breast cancer research group running academic clinical trials and translational studies. Closely comparable to ABCSG in terms of disease focus, non-profit academic structure, and reliance on pharma sponsorship for trials and education.
• SAKK (Swiss Group for Clinical Cancer Research): Swiss non-profit academic research organization coordinating investigator-initiated oncology trials across Swiss centers. Functionally analogous to ABCSG, with a slightly broader indication set and a neighboring-country profile.
• SOLTI Cancer Research Group: Spanish academic oncology research group focused on breast cancer clinical trials, with which ABCSG already collaborates via the Young European Workshop. Structurally equivalent: an independent, non-profit, breast-cancer-focused academic research organization running its own investigator-initiated trials and educational programs.

Regional players

• Arbeitsgemeinschaft Deutscher Tumorzentren (ADT): German association of regional tumor centers coordinating oncology research and quality assurance. Shares ABCSG's academic, multi-center coordination model but operates in a different country and a broader tumor mix.
• AGO (Arbeitsgemeinschaft Gynäkologische Onkologie): German breast and gynecological cancer research and guideline group running academic trials and CME programs. Directly comparable in oncology focus and CME-driven model, with a German rather than Austrian footprint.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/ABCSGVienna
• YouTubeyoutube.com/user/StudiengruppeABCSG
• LinkedInlinkedin.com/company/abcsg
• Instagraminstagram.com/abcsgvienna

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Austrian Breast & Colorectal Cancer Study Group